Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 883158712 | 8831587 | 12 | F | 20140901 | 20160913 | 20121009 | 20160919 | EXP | US-GLAXOSMITHKLINE-A0988657A | GLAXOSMITHKLINE | 53.24 | YR | F | Y | 0.00000 | 20160919 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 883158712 | 8831587 | 1 | PS | FLOLAN | EPOPROSTENOL SODIUM | 1 | Intravenous (not otherwise specified) | 18 NG/KG/MIN, CO | U | M197 | 20444 | 18 | DF | POWDER FOR INFUSION | |||||
| 883158712 | 8831587 | 2 | SS | FLOLAN | EPOPROSTENOL SODIUM | 1 | UNK | U | M461 | 20444 | POWDER FOR INFUSION | ||||||||
| 883158712 | 8831587 | 3 | SS | FLOLAN | EPOPROSTENOL SODIUM | 1 | UNK | U | R271A | 20444 | POWDER FOR INFUSION | ||||||||
| 883158712 | 8831587 | 4 | SS | FLOLAN | EPOPROSTENOL SODIUM | 1 | UNK | U | S276 | 20444 | POWDER FOR INFUSION | ||||||||
| 883158712 | 8831587 | 5 | SS | FLOLAN | EPOPROSTENOL SODIUM | 1 | UNK | U | S925 | 20444 | POWDER FOR INFUSION | ||||||||
| 883158712 | 8831587 | 6 | SS | FLOLAN | EPOPROSTENOL SODIUM | 1 | Intravenous (not otherwise specified) | 20.5 NG/KG/MIN, UNK | U | T366 | 20444 | 20.5 | DF | POWDER FOR INFUSION | |||||
| 883158712 | 8831587 | 7 | SS | FLOLAN | EPOPROSTENOL SODIUM | 1 | UNK | U | V380 | 20444 | POWDER FOR INFUSION | ||||||||
| 883158712 | 8831587 | 8 | SS | FLOLAN | EPOPROSTENOL SODIUM | 1 | 23.5 NG/KG/MIN | U | Z880 | 20444 | 23.5 | DF | POWDER FOR INFUSION | ||||||
| 883158712 | 8831587 | 9 | SS | FLOLAN | EPOPROSTENOL SODIUM | 1 | U | C764454 | 0 | SOLUTION FOR INJECTION | |||||||||
| 883158712 | 8831587 | 10 | C | Warfarin | WARFARIN | 1 | U | 0 | |||||||||||
| 883158712 | 8831587 | 11 | C | ADCIRCA | TADALAFIL | 1 | U | 0 | |||||||||||
| 883158712 | 8831587 | 12 | C | LETAIRIS | AMBRISENTAN | 1 | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 883158712 | 8831587 | 1 | Pulmonary arterial hypertension |
| 883158712 | 8831587 | 9 | Pulmonary arterial hypertension |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 883158712 | 8831587 | HO |
| 883158712 | 8831587 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 883158712 | 8831587 | Adverse drug reaction | |
| 883158712 | 8831587 | Adverse event | |
| 883158712 | 8831587 | Application site hypersensitivity | |
| 883158712 | 8831587 | Catheter management | |
| 883158712 | 8831587 | Diarrhoea | |
| 883158712 | 8831587 | Dysentery | |
| 883158712 | 8831587 | Dyspnoea exertional | |
| 883158712 | 8831587 | Headache | |
| 883158712 | 8831587 | Hot flush | |
| 883158712 | 8831587 | Multiple allergies | |
| 883158712 | 8831587 | Pain | |
| 883158712 | 8831587 | Pain in extremity | |
| 883158712 | 8831587 | Pain in jaw | |
| 883158712 | 8831587 | Pneumonitis | |
| 883158712 | 8831587 | Procedural complication | |
| 883158712 | 8831587 | Rash |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 883158712 | 8831587 | 1 | 20080609 | 0 | ||
| 883158712 | 8831587 | 2 | 20080609 | 0 | ||
| 883158712 | 8831587 | 3 | 20080609 | 0 | ||
| 883158712 | 8831587 | 4 | 20080609 | 0 | ||
| 883158712 | 8831587 | 7 | 20120202 | 0 | ||
| 883158712 | 8831587 | 8 | 20120202 | 0 |